Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Operating Expenses | 0 | 25,110 | 40,420 | 34,710 | 35,450 |
| Operating Income | N/A | -25,110 | -40,420 | -34,710 | -35,450 |
| Interest Expense | 0 | 2,210 | 3,140 | 0 | 1,720 |
| Other Income | 0 | -2,730 | -2,150 | 0 | 4,390 |
| Pre-tax Income | 0 | -30,050 | -45,710 | -34,710 | -32,780 |
| Net Income Continuous | N/A | -27,208 | -43,174 | -48,565 | -32,782 |
| Net Income | $N/A | $-30,050 | $-45,710 | $-48,565 | $-32,780 |
| EPS Basic Total Ops | N/A | -26.40 | -52.40 | -56.80 | -43.20 |
| EPS Basic Continuous Ops | N/A | -23.22 | -48.96 | -56.00 | -42.62 |
| EPS Diluted Total Ops | N/A | -26.40 | -52.40 | -56.80 | -43.20 |
| EPS Diluted Continuous Ops | N/A | -23.22 | -48.96 | -56.00 | -42.62 |
| EBITDA(a) | $N/A | $-22,270 | $-37,110 | $-32,320 | $-33,150 |